Literature DB >> 466868

Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.

E M Faed, E G McQueen.   

Abstract

1. The metabolites of clofibric acid [CPIB;2-(chlorophenoxy)-2-methylpropionic acid] are present in the plasma of patients on clofibrate therapy. The highest plasma concentrations of CPIB in metabolite form (up to 51 micrograms/ml) were generally found in patients with renal disease. Negligible concentrations (less than or equal to 2 micrograms/ml) were found in only seven patients out of thirty-six studied. 2. The two conjugates of CPIB found in urine were present in plasma. 3. When measuring conjugated CPIB in plasma it is essential to take care in the handling and storage of specimens, and to select an assay method known to be specific for unmetabolized CPIB.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 466868     DOI: 10.1111/j.1440-1681.1979.tb01248.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.

Authors:  R K Verbeeck; S M Wallace; G R Loewen
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

2.  Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

Authors:  E M Faed
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

Review 3.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.